We observed that when using the IGF-1 GG+GC genotype and BMI<24 kg/m2 as the reference group, carrying the IGF-1 GG+GC genotype with BMI ≥24 kg/m2 increased BC risk. This evidence concerns the gene IGF1 and breast cancer.